BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 17200338)

  • 1. Clonality and prognostic implications of p53 and epidermal growth factor receptor somatic aberrations in multiple primary lung cancers.
    Chang YL; Wu CT; Lin SC; Hsiao CF; Jou YS; Lee YC
    Clin Cancer Res; 2007 Jan; 13(1):52-8. PubMed ID: 17200338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New aspects of the clinicopathology and genetic profile of metachronous multiple lung cancers.
    Wu CT; Lin MW; Hsieh MS; Kuo SW; Chang YL
    Ann Surg; 2014 May; 259(5):1018-24. PubMed ID: 24368645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of epidermal growth factor receptor and human epidermal growth factor receptor 2 activating mutations in lung adenocarcinoma by high-resolution melting amplicon analysis: correlation with gene copy number, protein expression, and hormone receptor expression.
    Willmore-Payne C; Holden JA; Layfield LJ
    Hum Pathol; 2006 Jun; 37(6):755-63. PubMed ID: 16733218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of p53 and epidermal growth factor receptor gene status between primary tumors and lymph node metastases in non-small cell lung cancers.
    Chang YL; Wu CT; Shih JY; Lee YC
    Ann Surg Oncol; 2011 Feb; 18(2):543-50. PubMed ID: 20811949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical treatment of synchronous multiple primary lung cancers: experience of 92 patients.
    Chang YL; Wu CT; Lee YC
    J Thorac Cardiovasc Surg; 2007 Sep; 134(3):630-7. PubMed ID: 17723810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The survival outcomes of patients with resected non-small cell lung cancer differ according to EGFR mutations and the P21 expression.
    Na II; Rho JK; Choi YJ; Kim CH; Park JH; Koh JS; Ryoo BY; Yang SH; Lee JC
    Lung Cancer; 2007 Jul; 57(1):96-102. PubMed ID: 17337084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discrimination of multiple primary lung cancers from intrapulmonary metastasis based on the expression of four cancer-related proteins.
    Ono K; Sugio K; Uramoto H; Baba T; Ichiki Y; Takenoyama M; Hanagiri T; Oyama T; Yasumoto K
    Cancer; 2009 Aug; 115(15):3489-500. PubMed ID: 19452548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular context of the EGFR mutations: evidence for the activation of mTOR/S6K signaling.
    Conde E; Angulo B; Tang M; Morente M; Torres-Lanzas J; Lopez-Encuentra A; Lopez-Rios F; Sanchez-Cespedes M
    Clin Cancer Res; 2006 Feb; 12(3 Pt 1):710-7. PubMed ID: 16467080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathology and genetic profile of synchronous multiple small adenocarcinomas: implication for surgical treatment of an uncommon lung malignancy.
    Lin MW; Wu CT; Kuo SW; Chang YL; Yang PC
    Ann Surg Oncol; 2014 Aug; 21(8):2555-62. PubMed ID: 24643899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discrimination of double primary lung cancer from intrapulmonary metastasis by p53 gene mutation.
    Matsuzoe D; Hideshima T; Ohshima K; Kawahara K; Shirakusa T; Kimura A
    Br J Cancer; 1999 Mar; 79(9-10):1549-52. PubMed ID: 10188905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytomorphological correlates of epidermal growth factor receptor mutations in lung carcinoma.
    Brachtel EF; Iafrate AJ; Mark EJ; Deshpande V
    Diagn Cytopathol; 2007 May; 35(5):257-62. PubMed ID: 17427221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carcinogen exposure, p53 alteration, and K-ras mutation in synchronous multiple primary lung carcinoma.
    Wang X; Christiani DC; Mark EJ; Nelson H; Wiencke JK; Gunn L; Wain JC; Kelsey KT
    Cancer; 1999 Apr; 85(8):1734-9. PubMed ID: 10223567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract.
    Chung KY; Mukhopadhyay T; Kim J; Casson A; Ro JY; Goepfert H; Hong WK; Roth JA
    Cancer Res; 1993 Apr; 53(7):1676-83. PubMed ID: 8453641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High frequency of clonally related tumors in cases of multiple synchronous lung cancers as revealed by molecular diagnosis.
    Shimizu S; Yatabe Y; Koshikawa T; Haruki N; Hatooka S; Shinoda M; Suyama M; Ogawa M; Hamajima N; Ueda R; Takahashi T; Mitsudomi T
    Clin Cancer Res; 2000 Oct; 6(10):3994-9. PubMed ID: 11051248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unique p53 and epidermal growth factor receptor gene mutation status in 46 pulmonary lymphoepithelioma-like carcinomas.
    Chang YL; Wu CT; Shih JY; Lee YC
    Cancer Sci; 2011 Jan; 102(1):282-7. PubMed ID: 21070477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P53 and EGFR expression in colorectal cancer: a reappraisal of 'old' tissue markers in patients with long follow-up.
    Theodoropoulos GE; Karafoka E; Papailiou JG; Stamopoulos P; Zambirinis CP; Bramis K; Panoussopoulos SG; Leandros E; Bramis J
    Anticancer Res; 2009 Feb; 29(2):785-91. PubMed ID: 19331236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Assessment of prognosis and p 53 mutations in patients with multiple tumors of the lung; intrapulmonary metastasis or double primary cancers?].
    Osaki T; Oyama T; Takenoyama M; Taga S; So T; Yamashita T; Nakata S; Sugio K; Yasumoto K
    Kyobu Geka; 2002 Jan; 55(1):25-9. PubMed ID: 11797404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High frequency and heterogeneous distribution of p53 mutations in aflatoxin B1-induced mouse lung tumors.
    Tam AS; Foley JF; Devereux TR; Maronpot RR; Massey TE
    Cancer Res; 1999 Aug; 59(15):3634-40. PubMed ID: 10446974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of EGFR mutations with chromosomal alterations and expression of EGFR, ErbB3 and VEGF in tumor samples of lung adenocarcinoma patients.
    Reinmuth N; Jauch A; Xu EC; Muley T; Granzow M; Hoffmann H; Dienemann H; Herpel E; Schnabel PA; Herth FJ; Gottschling S; Lahm H; Steins M; Thomas M; Meister M
    Lung Cancer; 2008 Nov; 62(2):193-201. PubMed ID: 18450321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of EGFR, HER2, TP53, and KRAS mutations of p14arf expression in non-small cell lung cancers in relation to smoking history.
    Mounawar M; Mukeria A; Le Calvez F; Hung RJ; Renard H; Cortot A; Bollart C; Zaridze D; Brennan P; Boffetta P; Brambilla E; Hainaut P
    Cancer Res; 2007 Jun; 67(12):5667-72. PubMed ID: 17575133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.